We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Devicemakers Could Trim Costs With Joint FDA-CMS Meetings
Devicemakers Could Trim Costs With Joint FDA-CMS Meetings
April 2, 2010
Devicemakers may save substantial time and money by holding joint meetings with the FDA and Centers for Medicare & Medicaid Services (CMS) early on
to discuss clinical trial designs.